Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Revenue

Avadel Pharmaceuticals had revenue of $77.47M in the quarter ending September 30, 2025, with 54.86% growth. This brings the company's revenue in the last twelve months to $248.52M, up 79.88% year-over-year. In the year 2024, Avadel Pharmaceuticals had annual revenue of $169.12M with 504.79% growth.

• Revenue (ttm): $248.52M
• Revenue Growth: +79.88%
• P/S Ratio: 8.96
• Revenue / Employee: $1,321,899
• Employees: 188
• Market Cap: 2.25B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	169.12M	141.15M	504.79%
Dec 31, 2023	27.96M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	22.33M	-36.88M	-62.28%